Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022
Loading...
Date
2024-04
Journal Title
Journal ISSN
Volume Title
Publisher
Centers for Disease Control and Prevention
Abstract
Abstract
Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine. No safety signals were identified using a multipronged approach of passive and active surveillance.
Description
Keywords
vaccine-related paralysis; novel oral poliovirus vaccine type 2; Safety Evaluation; Immunization; Uganda
Citation
Tobolowsky, Farrell A., Fred Nsubuga, Zunera Gilani, et al. 'Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022', Emerging Infectious Diseases, vol. 30/no. 4, (2024), pp. 775-778.